What birth defects have been linked to lurbinectedin?
Based on the information provided, there are no specific birth defects listed as being linked to lurbinectedin exposure.
What does the available information say about pregnancy risk with lurbinectedin?
The provided information does not include pregnancy or reproductive-risk details that identify a pattern of congenital anomalies or specific birth defects related to lurbinectedin.
Is lurbinectedin considered teratogenic, even if specific defects aren’t listed?
The provided information does not state that lurbinectedin is teratogenic or name particular fetal effects. Without that data in the provided material, the existence of a specific birth-defect signal cannot be confirmed.
What should someone exposed to lurbinectedin during pregnancy do?
The provided information does not include guidance for pregnancy exposure management. In practice, people with possible exposure typically need prompt contact with their oncology and obstetric team for risk assessment and monitoring, but the specific steps cannot be confirmed from the material you supplied.
Can birth defects be caused without a specific lurbinectedin-linked pattern being documented?
Yes. A drug can still pose fetal risk even if no specific birth defects are explicitly reported in the available text, but the provided information does not supply enough detail to identify whether lurbinectedin does or does not cause particular defects.
If you share the source text you’re working from (for example, a label section, study excerpt, or guideline language), I can extract exactly what it says about congenital anomalies and pregnancy outcomes.
Sources: none (no provided information to cite).